Thalidomide is a drug that is used to treat multiple myeloma in patients who have just been diagnosed, and a painful skin disease related to leprosy. It is also being studied in the treatment of other types of cancer. Thalidomide belongs to the family of drugs called angiogenesis inhibitors. Also called Thalomid.
Protein degraders, which cause target proteins to break down, are thought to be the “next-generation drugs” because they may eliminate disease-causing proteins from cells.
Despite immense efforts to improve pharmacology methods, over three-quarters of all human proteins still remain beyond the reach of therapeutic advancement.
Numerous therapeutic compounds—such as amino acids, enzymes, and proteins— that are currently available in the market are “chiral compounds.”
Researchers from the University of Cambridge have devised a new model to analyze an early stage of human development through human embryonic stem cells.